• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate (CAS No. 111304-31-5): A Comprehensive Overview

Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate, a compound with the CAS number 111304-31-5, has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural and functional properties. This compound, featuring a nitrophenyl moiety and an acrylate-like functionality, presents a versatile scaffold for the development of novel bioactive molecules.

The structural motif of Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate consists of an ester group linked to an α,β-unsaturated carbonyl system, which is further substituted with a nitrophenyl ring. This arrangement not only contributes to the compound's reactivity but also enhances its potential biological activity. The presence of the nitro group, in particular, has been extensively studied for its ability to modulate various biological pathways, making it a valuable component in drug discovery efforts.

In recent years, there has been a growing interest in the development of molecules that can interact with biological targets in a highly specific manner. Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate has emerged as a promising candidate in this regard. Its ability to engage with biological systems through multiple mechanisms has led to its exploration in various therapeutic areas, including oncology, inflammation, and neurodegenerative diseases.

One of the most compelling aspects of Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate is its potential as a tool for studying enzyme inhibition and receptor binding. The compound's acrylate functionality allows it to participate in Michael addition reactions, which are commonly observed in biological systems. This reactivity makes it an excellent candidate for developing inhibitors targeting enzymes such as cyclooxygenases (COX) and lipoxygenases (LOX), which play crucial roles in inflammatory processes.

Recent studies have demonstrated the efficacy of derivatives of Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate in modulating inflammatory pathways. For instance, researchers have reported the synthesis and characterization of several analogs that exhibit significant anti-inflammatory activity in vitro and in vivo. These findings highlight the compound's potential as a lead molecule for the development of novel anti-inflammatory drugs.

The nitro group present in Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate also contributes to its biological activity by serving as a hydrogen bond acceptor. This feature is particularly important for interactions with proteins and nucleic acids, which often rely on hydrogen bonding for stable binding. The ability to form multiple hydrogen bonds enhances the compound's binding affinity and selectivity towards target molecules.

In addition to its role in drug development, Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate has found applications in materials science and chemical synthesis. Its unique reactivity makes it a valuable building block for constructing more complex molecules with tailored properties. Researchers have leveraged its acrylate functionality to develop novel polymers and coatings that exhibit enhanced durability and biocompatibility.

The synthesis of Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate involves several key steps that highlight the compound's synthetic versatility. The reaction typically begins with the condensation of 2-nitrophthalic anhydride with methyl acetoacetate, followed by hydrolysis and decarboxylation to yield the desired product. This synthetic route underscores the compound's accessibility and feasibility for large-scale production.

The chemical properties of Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate have also been thoroughly investigated. Spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry have been employed to elucidate its molecular structure and confirm its identity. These studies have provided valuable insights into the compound's reactivity and stability under various conditions.

In conclusion, Methyl 2-(2-Nitrophenyl)methylidene-3-oxobutanoate (CAS No. 111304-31-5) is a multifaceted compound with significant potential in pharmaceutical research and industrial applications. Its unique structural features, including the presence of a nitro group and an acrylate-like functionality, make it an attractive scaffold for developing novel bioactive molecules. The growing body of research on this compound underscores its importance as a tool for exploring new therapeutic strategies and materials science innovations.

• 39562-27-1(2-(2-Nitrobenzylidene)-3-oxobutanoic Acid, Methyl Ester)
• 119128-13-1((Z)-Methyl 2-(3-Nitrobenzylidene)-3-oxobutanoate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)